Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff


Posted on: 07 Dec 17

Copenhagen, 2017-12-07 13:51 CET (GLOBE NEWSWIRE) --  

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) reports the following transactions: 

1. Details of the person discharging managerial responsibility / person closely associated
a) Name Lene Skole
2. Reason for the notification
a) Position/status Member of the Board of Directors
b) Initial notification/
amendment
Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name ALK-Abelló A/S
b) LEI 529900SGCREUZCZ7P020
4. Details of the transaction(s): section to be repeated for (i) each type of instrument: (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code
B shares
 
 
DK0060027142
b) Nature of the transaction Purchase of shares
c) Price(s) and volume(s) Price(s) Volume(s)
    DKK 440,925  600
d) Aggregated information
- Aggregated volume
- Price
 
600
DKK 440,925
e) Date of the transaction 2017-12-07
f) Place of the transaction NASDAQ Copenhagen

  

1. Details of the person discharging managerial responsibility / person closely associated
a) Name Steen Riisgaard
2. Reason for the notification
a) Position/status Member of the Board of Directors
b) Initial notification/
amendment
Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name ALK-Abelló A/S
b) LEI 529900SGCREUZCZ7P020
4. Details of the transaction(s): section to be repeated for (i) each type of instrument: (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code
B shares
 
 
DK0060027142
b) Nature of the transaction Purchase of shares
c) Price(s) and volume(s) Price(s) Volume(s)
    DKK 742,920   1,000
d) Aggregated information
- Aggregated volume
- Price
 
1,000
DKK 742,920
e) Date of the transaction 2017-12-07
f) Place of the transaction NASDAQ Copenhagen

  
ALK-Abelló A/S

 

For further information please contact:
Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525

GlobeNewswire
globenewswire.com

Last updated on: 07/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.